4.1 Article

Expert Views on Innovative Future Uses for Contact Lenses

期刊

OPTOMETRY AND VISION SCIENCE
卷 93, 期 4, 页码 328-335

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/OPX.0000000000000700

关键词

drug delivery; limbal stem cell deficiency; visual displays; contact lens; myopia control

资金

  1. Advanced Vision Research
  2. Alcon
  3. AlgiPharma
  4. Allergan
  5. CIBA Vision
  6. CooperVision
  7. Essilor
  8. JJ Vision Care
  9. Ocular Dynamics
  10. Oculus
  11. Ocusense
  12. TearScience Technology
  13. Visioneering Technology

向作者/读者索取更多资源

Over the past 10 to 15 years, the availability of new materials and technologies has resulted in revolutionary concepts for contact lenses being proposed that go well beyond correcting vision. These novel uses include their prescribing to deliver topical ocular and systemic drugs, assist with ocular surface disease management, and limit the progression of myopia and novel methods to display visual information. How likely are these concepts to become commercially available, how successful will they be, and what are the potential issues to consider for them to come to market? To answer these questions, a panel of four experts were invited to discuss the benefits and pitfalls of these technologies and what challenges lay ahead of these concepts before their availability. Their responses provide a fascinating insight for the clinician into the likelihood of such revolutionary contact lenses being available in a clinical setting.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据